C12N 2710/20043
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2710/20043 (Viral genome or elements thereof as genetic vector) appears on 23 US grants and 34 published applications in this corpus.
Search patents in C12N- Granted patents
- 23
- Published applications
- 34
- Assignees
- 25
- Inventors
- 84
- Latest grant
- 5 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 2 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 3 |
| 2008 | 0 | 0 |
| 2009 | 2 | 1 |
| 2010 | 1 | 2 |
| 2011 | 1 | 4 |
| 2012 | 2 | 2 |
| 2013 | 0 | 0 |
| 2014 | 1 | 2 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 2 | 2 |
| 2018 | 0 | 2 |
| 2019 | 0 | 2 |
| 2020 | 0 | 3 |
| 2021 | 1 | 2 |
| 2022 | 0 | 0 |
| 2023 | 1 | 2 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Recombinant pseudocowpoxvirus5 Aug 2025US 12,377,142 B2Transgene S. A.
- Intratumoral vaccination10 Jan 2023US 11,548,930 B2Heat Biologics, Inc.
- Mutant of L1 protein of human papillomavirus type 589 Mar 2021US 10,940,194 B2Xiamen Innovax Biotech Co., Ltd.
- Polyionic papilloma virus-like particle (VLP) vaccines28 Feb 2017US 9,580,474 B2The Johns Hopkins University
- Method of treating stomach or bowel-related disorders by administering glucagon-like-peptide-2 (GLP-2) analogues28 Feb 2017US 9,580,487 B2Zealand Pharma A/S
- Glucagon-like-peptide-2 (glp-2) analogues17 Apr 2025US 2025/0122260 A1Zealand Pharma A/S
- Intratumoral vaccination28 Sep 2023US 2023/0303659 A1Heat Biologics, Inc.
- Process for producing a prophylactic and therapeutic dna immunological composition for hpv and cancers associated with the virus, hybrid protein, expression vector, immunological composition and uses thereof14 Sep 2023US 2023/0285533 A1Instituto Butantan
- Glucagon-like-peptide-2 (glp-2) analogues7 Oct 2021US 2021/0309708 A1Zealand Pharma A/S
- Parapoxvirus vectors7 Jan 2021US 2021/0000937 A1Transgene S. A.
Most cited
By later US patents
- Recombinant DNA process utilizing a papilloma virus DNA as a vector284US 4,419,446 AThe United States of America as represented by the Department of Health and Human Services · 1983
- Mammalian metallothionein promoter system224US 4,601,978 AThe Regents of the University of California · 1986
- Episomal vector systems and related methods81US 5,674,703 A1997
- Human papilloma virus vectors37US 6,399,383 B1Maxygen, Inc. · 2002
- Vectors for DNA immunization against cervical cancer28US 6,235,523 B1Connaught Laboratories Limited · 2001